Comparative Immunogenicity and Safety of SpikoGen®, a Recombinant SARS-CoV-2 Spike Protein Vaccine in Children and Young Adults: an Immuno-Bridging Clinical Trial
INTERNATIONAL IMMUNOPHARMACOLOGY（2024）
Key words
SpikoGen,COVID-19,children,SARS-CoV-2,Subunit vaccine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined